SUN-101 (glycopyrrolate) is a long-acting muscarinic antagonist (LAMA) bronchodilator delivered via the innovative, proprietary eFlow nebulizer closed system. Developed by PARI Pharma, eFlow is a ...

To be effective in treating respiratory illnesses, liquid drugs must be utilized in an aerosol with an effective and defined drop size distribution for inhaled medications. To meet these intense ...

The MiniElite compressor nebulizer system is compact, lightweight, and designed for patient convenience. It can be powered by three versatile power sources- 110V AC, 12V DC (car) and an optional ...

NESS ZIONA, Israel--(BUSINESS WIRE)--Kamada Ltd. (NASDAQ:KMDA) (TASE:KMDA), a plasma-derived protein therapeutics company focused on orphan indications, reports that the Israeli Patent Office (ILPO) ...

Lonhala Magnair is available as a 25mcg strength inhalation solution per 1mL vial. Sunovion announced the launch of Lonhala Magnair (glycopyrrolate) inhalation solution for the long-term, maintenance ...

- LONHALA MAGNAIR is the first nebulized long-acting muscarinic antagonist (LAMA) available for the treatment of COPD in the U.S. - MARLBOROUGH, Mass.--(BUSINESS WIRE)--Sunovion Pharmaceuticals Inc.

The US Food and Drug Administration (FDA) has approved the eRapid nebulizer system (PARI), the first electronic nebulizer to deliver dornase alfa (Pulmozyme, Genentech) for the treatment of cystic ...

Respiratory devicemaker PARI picked up an approval from the FDA for its eRapid nebulizer system, which is the first electronic one to deliver Genentech's cystic fibrosis treatment Pulmozyme. A ...

DUBLIN, Aug. 12, 2021 /PRNewswire/ -- The "Global Nebulizer System Market, By Product Type (Jet Nebulizer System, Mesh Nebulizer System, Ultrasonic Nebulizer System), By Accessories (Main Apparatus ...

RICHMOND, Va., Jan. 26, 2015 /PRNewswire/ -- The eRapid Nebulizer System (eRapid) from PARI has been approved as the first electronic nebulizer by the Food and Drug Administration to deliver Genentech ...

U.S. Food and Drug Administration Approves Cayston(R) (Aztreonam for Inhalation Solution) for the Improvement of Respiratory Symptoms in Cystic Fibrosis Patients with Pseudomonas Aeruginosa - First ...

Question: I recently filled my nebulizer medication at the pharmacy and had to pay full price. Why did that happen this time? Answer: Usually when individuals ask about medication coverage the answer ...